Concepedia

Whitney L. Petrilli

WL

Statistics

Publications

3

Citations

115

H-Index

3

Active since

2015

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Whitney L. Petrilli is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, drug design, and medicinal chemistry.

ORCID

Publications per year

2015–2019

3

Publications

3

From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9

Whitney L. Petrilli, Gregory C. Adam, Roman S. Erdmann et al. · Cell chemical biology · 2019 · 83 citations · Full text

, , +12

Discovery of Triazole CYP11B2 Inhibitors with in Vivo Activity in Rhesus Monkeys

Scott B. Hoyt, Whitney L. Petrilli, Clare London et al. · ACS Medicinal Chemistry Letters · 2015 · 18 citations · Full text

, , +17

Discovery of Spirocyclic Aldosterone Synthase Inhibitors as Potential Treatments for Resistant Hypertension

Whitney L. Petrilli, Scott B. Hoyt, Clare London et al. · ACS Medicinal Chemistry Letters · 2016 · 14 citations · Full text

, , +17

1–3 of 3